TABLE 1.
Characteristics | PP (n = 224) | CS (n = 232) | p Value |
---|---|---|---|
Age ‡ , † | 50 (36–59) | 38 (25–48) | <0.0001 |
Gender, n (%) | |||
Female | 86 (38) | 129 (56) | <0.001 |
Male | 138 (62) | 103 (44) | |
Time of evolution of the disease § , ¶ | 10 ± 0.63 | ‐ | |
PASI § , ¶ | 6 ± 0.46 | ‐ | |
Treatment, n (%) | |||
Topical (exfoliants) | 78 (35) | ‐ | |
Systemic | 77 (34) | ‐ | |
Without | 69 (31) | ‐ | |
Comorbidities, n (%) | |||
Obesity | 15 (7) | ‐ | |
Hypertension | 25 (11) | ‐ | |
Hypercholesterolemia | 9 (4) | ‐ |
Abbreviations: CS, Control subjects; PP, plaque psoriasis patients.
Data are expressed as median (p25th–p75th).
Data are expressed as mean ± standard error.